Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,081 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Loss of H3K9 trimethylation leads to premature aging.
Ocampo A, Mrabti C, Yang N, Desdín-Micó G, Alonso-Calleja A, Vílchez-Acosta A, Pico S, Parras A, Piao Y, Schoenfeldt L, Luo S, Haghani A, Brooke RT, Maza MDC, Branchina C, Maroun CY, von Meyenn F, Naveiras O, Horvath S, Sen P, Bignon Y. Ocampo A, et al. Among authors: yang n. Res Sq [Preprint]. 2024 Dec 16:rs.3.rs-4012025. doi: 10.21203/rs.3.rs-4012025/v1. Res Sq. 2024. PMID: 39764087 Free PMC article. Preprint.
The Oxidoreductase Retinol Saturase in Thyroid Gland Is Regulated by Hypothyroidism and Iodide Overload and Its Deletion Impairs Metabolic Homeostasis in Mice.
Yang N, Wessoly L, Meng Y, Kiefer MF, Chen Y, Vahrenbrink M, Wulff S, Li C, Schreier JW, Steinhoff JS, Oster M, Sommerfeld M, Wowro SJ, Petricek KM, Flores RE, Ziros PG, Sykiotis GP, Wirth EK, Schupp M. Yang N, et al. Antioxid Redox Signal. 2025 Jan 6. doi: 10.1089/ars.2023.0458. Online ahead of print. Antioxid Redox Signal. 2025. PMID: 39761014
Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases.
Li L, Huang Z, Chen Y, Ma H, Chen X, Yan H, Qin H, Zhang Y, Zhang X, Jiang W, Wang Z, Zhang L, Zeng F, Zhou Z, Pu X, Yang N, Zeng L, Zhang Y. Li L, et al. Among authors: yang n. Heliyon. 2024 Dec 7;10(24):e40703. doi: 10.1016/j.heliyon.2024.e40703. eCollection 2024 Dec 30. Heliyon. 2024. PMID: 39759323 Free PMC article.
A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001).
Chen HJ, Tu HY, Hu Y, Fan Y, Wu G, Cang S, Yang Y, Yang N, Ma R, Jin G, Xu X, Liu A, Tang S, Cheng Y, Yu Y, Xu CR, Zhou Q, Wu YL. Chen HJ, et al. Among authors: yang n. J Hematol Oncol. 2025 Jan 5;18(1):3. doi: 10.1186/s13045-024-01656-0. J Hematol Oncol. 2025. PMID: 39757186 Free PMC article. Clinical Trial.
7,081 results